Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The user has high DHT levels despite using dutasteride, which may not be effective due to potential damage or spoilage. They are considering a hair transplant if DHT levels don't decrease after two years.

Dutasteride mesotherapy may not affect serum DHT levels significantly and its impact on scalp DHT is uncertain. Its systemic accumulation depends on dose and frequency.

The user is exploring the use of low-dose corticosteroids, specifically hydrocortisone, to treat hair thinning associated with DUPA, alongside finasteride, oral minoxidil, pyrilutamide, and keto shampoo. They are cautious about long-term steroid use due to potential side effects and are considering dietary changes to address possible autoimmune connections.

Dermastamp is preferred for hair growth and skin health due to fewer scars, with recommended needle sizes of 0.5-1.5mm. Dermapen is also favored over dermarollers, which are considered dangerous.

Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.

A user tried the Rapid Minoxidil Response Test (TrichoGene) and found they don't respond to topical Minoxidil, so they added tretinoin. The test is available internationally, and another user is considering ordering it.

OP developed hives after using Kx 826 (Pyrilutamide) 1% twice daily for 3 weeks. The hives appeared on the arms, chest, and groin area.

The conversation discusses the comparison between Dr.Pen M8S and Derminator 2 for microneedling, with a focus on pain and technique, recommending a stamping motion to avoid micro-tears. Users also discuss sanitizing methods for reusable stamps and suggest using numbing cream for pain management.

Deuruxolitinib, combined with two other drugs, shows promise in regrowing significant hair in severe alopecia areata patients. This new treatment approach could become a standard of care, offering hope for those with limited options.

A 22-year-old male uses dutasteride, a serum with 10% minoxidil and 0.5% finasteride, and microneedling for diffuse androgenetic alopecia. Progress pictures show changes from July 2025 to February 2026.

A user shared a new hair loss treatment protocol including topical dutasteride, latanoprost, caffeine, minoxidil, tretinoin, and triamcinolone acetonide. Others discussed the effectiveness and availability of these treatments, with some suggesting simpler oral alternatives.

The conversation discusses using a derma stamp with titanium needles for microneedling to promote hair regrowth, particularly in the temples, alongside a topical treatment of Minoxidil, Finasteride, and Tretinoin. Users share tips on maintaining the derma stamp, such as cleaning with alcohol, and suggest using a derma pen for better results.

Topical dutasteride with microneedling and mesotherapy dutasteride injections are effective treatments for androgenetic alopecia in both men and women. These methods offer promising alternatives to oral therapies with potentially fewer systemic side effects.

The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.

Hair follicles cannot be desensitized to DHT like allergies; treatments focus on reducing DHT levels or blocking its effects using methods like finasteride, GT20029, or PROTACs. Topical treatments like ceterizine and BPA application are also mentioned.

Dutasteride mesotherapy for hair loss, with the user reporting minimal pain during the procedure. Other users mention success stories and inquire about additional treatments.

The user experienced severe scalp itching and hair loss while on dutasteride, which they linked to caffeine and masturbation. They plan to cut out both to see if their hair density improves.

The conversation is about making a topical solution from clascoterone powder, with references to using a RU58841 mixing guide for guidance. Concerns about product authenticity and bulk purchase requirements are also discussed.

The conversation is about finding a dermatologist in New York City for dutasteride mesotherapy. Alternatives like micro-needling with personal solutions are also discussed.

Oral PTD-DBM was discussed as a potential hair loss treatment, but it was deemed ineffective in humans despite promising results in mice. The conversation concluded that trying it without VPA might be unwise.

A product called HairMDL includes Minoxidil, Dutasteride, Latanoprost, caffeine, Tretinoin, and Triamcinolone. Users are curious about its effectiveness and safety, particularly regarding the topical steroid Triamcinolone.

The conversation is about using a derma stamp with Minoxidil, finasteride, and Kera serum for hair growth. The user seeks advice on cleaning the application area, finding needle cartridges, and the appropriate needle depth and frequency to avoid follicle damage.

RU58841 helped reduce scalp itching for some users within a week, while others experienced immediate relief. Some users reported initial irritation from the solution, possibly due to the carrier used.

A user is seeking advice on adding dutasteride to their finasteride regimen to stop DHT-related scalp itch. They have tried selenium sulfide and ketoconazole shampoos with temporary success.